Documentário | China 2030: How China May Soon Lead the Bio-Revolution

Bloomberg | Beijing has poured billions of dollars into biotechnology as the sector undergoes a momentous expansion. Artificial intelligence, gene editing and synthetic biology may be the cornerstones of the next great industrial revolution. And China may lead it.

In this episode of China 2030, Bloomberg explores how China’s focus on pivoting from generic drug manufacturing to maker of first-in-class pharmaceuticals not only jump-started the country’s biotech sector, but laid a path to compete — and cooperate — with western pharma-giants.

Assista na íntegra

Artigos relacionados